Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,470 | -14,280 | -17,140 | -12,670 | -5,490 |
| Depreciation Amortization | 310 | 440 | 470 | 370 | 290 |
| Other Working Capital | 1,610 | 50 | 580 | 430 | 920 |
| Other Operating Activity | 60 | 520 | 370 | 120 | 270 |
| Operating Cash Flow | $-14,490 | $-13,270 | $-15,720 | $-11,750 | $-4,010 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -170 | -70 | -650 | -880 | -310 |
| Other Investing Activity | 7,820 | 15,500 | 470 | 28,100 | -61,780 |
| Investing Cash Flow | $7,650 | $15,430 | $-180 | $27,220 | $-62,090 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 15,440 | 4 | 20 | 100 | 62,760 |
| Financing Cash Flow | $15,440 | $4 | $20 | $100 | $62,760 |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | -40 |
| Beginning Cash Position | 4,180 | 2,010 | 17,890 | 2,320 | 5,710 |
| End Cash Position | 12,780 | 4,180 | 2,010 | 17,890 | 2,320 |
| Net Cash Flow | $8,600 | $2,160 | $-15,880 | $15,570 | $-3,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,490 | -13,270 | -15,720 | -11,750 | -4,010 |
| Free Cash Flow | -14,490 | -13,270 | -15,720 | -11,750 | -4,010 |